Showing results (91-100 of 153) with videos related to

Sort By:
Pageof 16
Respiratory Medicine|June 3, 2011
HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibodyKiminobu Tanizawa, Tomohiro Handa, Ran Nakashima, et al.
Respiratory Medicine|June 12, 2010
Importance of the PaCO(2) from 3 to 6 months after initiation of long-term non-invasive ventilationTomomasa Tsuboi, Motoharu Ohi, Toru Oga, et al.
The Clinical Respiratory Journal|July 21, 2021
Comparison between tools for measuring breathlessness: Cross-sectional validation of the Japanese version of the Dyspnoea-12Koichi Nishimura, Toru Oga, Kazuhito Nakayasu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 18, 2021
A novel automated immunoassay for serum NY-ESO-1 and XAGE1 antibodies in combinatory prediction of response to anti-programmed cell death-1 therapy in non-small-cell lung cancerYumiko Sakai, Koji Kurose, Kanako Sakaeda, et al.
Respirology (Carlton, Vic.)|September 25, 2008
Acylated ghrelin level in patients with OSA before and after nasal CPAP treatmentKen-ichi Takahashi, Kazuo Chin, Takashi Akamizu, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|August 19, 2016
Platelet aggregability in patients with interstitial pneumoniasTomohiro Handa, Kizuku Watanabe, Kiminobu Tanizawa, et al.
Respiration; International Review of Thoracic Diseases|September 25, 2009
Relationship between small airway function and health status, dyspnea and disease control in asthmaTomoshi Takeda, Toru Oga, Akio Niimi, et al.
Journal of Atherosclerosis and Thrombosis|December 25, 2009
Effects of obstructive sleep apnea with intermittent hypoxia on platelet aggregabilityToru Oga, Kazuo Chin, Arata Tabuchi, et al.
Cancer Chemotherapy and Pharmacology|January 24, 2025
HMGB1 assists the predictive value of tumor PD-L1 expression for the efficacy of anti-PD-1/PD-L1 antibody in NSCLCKunihiko Funaishi, Kakuhiro Yamaguchi, Hiroki Tanahashi, et al.
Pageof 16